Tower Research Capital LLC (Trc) Insmed Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Insmed Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 45,235 shares of INSM stock, worth $7.38 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
45,235
Previous 7,415
510.05%
Holding current value
$7.38 Million
Previous $565,000
705.66%
% of portfolio
0.13%
Previous 0.02%
Shares
32 transactions
Others Institutions Holding INSM
# of Institutions
582Shares Held
203MCall Options Held
2.84MPut Options Held
3.26M-
Darwin Global Management, Ltd. St. Helier, Y919.3MShares$3.16 Billion82.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$2.88 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$2.33 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$1.83 Billion0.13% of portfolio
-
Baker Bros. Advisors LP New York, NY7.71MShares$1.26 Billion7.87% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $22.1B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...